# Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome

> **NCT05976204** · — · COMPLETED · sponsor: **National Cardiovascular Center Harapan Kita Hospital Indonesia** · enrollment: 501 (actual)

## Conditions studied

- Congenital Heart Disease
- Tetralogy of Fallot
- Neutrophil-lymphocyte Ratio
- Absolute Lymphocyte Count
- Thrombocyte-lymphocyte Ratio
- Outcome
- TOF

## Interventions

- **PROCEDURE:** ToF primary repair

## Key facts

- **NCT ID:** NCT05976204
- **Lead sponsor:** National Cardiovascular Center Harapan Kita Hospital Indonesia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 501 (ACTUAL)
- **Last updated:** 2023-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05976204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05976204, "Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05976204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*